Kraig Biocraft Laboratories (KBLB) Payables (2010 - 2025)

Kraig Biocraft Laboratories (KBLB) has 16 years of Payables data on file, last reported at $1.8 million in Q4 2025.

• For the quarter ending Q4 2025, Payables fell 15.28% year-over-year to $1.8 million; the trailing twelve-month figure through Dec 2025 stood at $1.8 million (down 15.28% YoY), and the FY2025 full-year result was $1.8 million, down 15.28% from the prior year.
• Payables declined to $1.8 million in Q4 2025, from $1.9 million in the prior quarter.
• In the past five years, Payables ranged from a high of $9.2 million in Q1 2025 to a low of $931640.0 in Q1 2021.
• A 5-year average of $3.6 million and a median of $2.1 million in 2021 frame the typical range for Payables.
• Across the five-year window, Payables surged 571.91% in 2022 and plunged 77.46% in 2025, its largest moves.
• Tracing KBLB's Payables over 5 years: stood at $1.1 million in 2021, then surged by 571.91% to $7.3 million in 2022, then increased by 11.86% to $8.2 million in 2023, then plunged by 74.16% to $2.1 million in 2024, then declined by 15.28% to $1.8 million in 2025.
• Business Quant data shows KBLB's Payables at $1.8 million in Q4 2025, $1.9 million in Q3 2025, and $1.9 million in Q2 2025.